FOCUS Investment Banking and FOCUS Capital Partners Strengthen Ties Alongside Ownership Transition
Washington, D.C. and Dublin, Ireland — January 23, 2025 ...
FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023
Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...
Clinart, Inc. has been acquired by Clinical Trial & Consulting (CTI)
Washington, DC, (August 31, 2020) – FOCUS Investment Banking (“FOCUS”), ...
FOCUS Investment Banking Represents Clinart in its Acquisition by Greater Cincinnati-based CTI Clinical Trial and Consulting Services
FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.
Medvance (Selby, England) has been acquired by NAMSA (Northwood, Ohio).
Washington, DC (January 7, 2014) FOCUS, a national middle market ...
Pleiad Devices, Ltd. (Stirling, Scotland) has been acquired by Cromsource SRL (Verona, Italy).
Washington, DC (June 4, 2012) – FOCUS LLC, a national ...
Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010
Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.
Bioline has been acquired by Meridian Bioscience, Inc.
Washington DC (July 23, 2010) – FOCUS LLC, a national ...
